BI-FUNCTIONAL SHORT HAIRPIN RNA (BI-SHRNA): DESIGN AND PATHWAY TO CLINICAL APPLICATION
Bifunctional Short Hairpin RNA (bi-shRNA): Design and Pathway to Clinical Application (Chapter 14). In: siRNA Design: Methods and Protocols.
Archive for Publications
LONG TERM FOLLOW UP: PHASE I TRIAL OF “BI-SHRNA FURIN/GMCSF DNA/AUTOLOGOUS TUMOR CELL” IMMUNOTHERAPY (FANG™) IN ADVANCED CANCER
Phase I Trial of “bi-shRNA furin/GMCSF DNA/Autologous Tumor Cell” Immunotherapy (FANG™) in Advanced Cancer.
PHASE I STUDY OF A SYSTEMICALLY DELIVERED P53 NANOPARTICLE IN ADVANCED SOLID TUMORS
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors.
ASSESSMENT OF INTRAVENOUS PBI-SHRNA PDX1 NANOPARTICLE (OFHIRNA-PDX1) IN YUCATAN SWINE
Assessment of Intravenous pbi-shRNA PDX1 Nanoparticle (OFHIRNA-PDX1) in Yucatan Swine.
“ELLIS ET AL DESCRIBE AND JUSTIFY THE…” OF: [ELLIS M.J ET AL. CONNECTING GENOMIC ALTERATIONS TO CANCER BIOLOGY WITH PROTEOMICS: THE NCI CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM. CANCER DISCOVERY,
“Ellis et al describe and justify the…” of: [Ellis M.J et al. Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium.
A FIRST IN HUMAN PHASE 1 STUDY OF CG0070, A GM-CSF EXPRESSING ONCOLYTIC ADENOVIRUS, FOR THE TREATMENT OF NONMUSCLE INVASIVE BLADDER CANCER
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer.
MG98, A SECOND GENERATION DNMT1 INHIBITOR, IN THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
MG98, A Second Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma.
FIRST-IN-MAN APPLICATION OF A NOVEL THERAPEUTIC CANCER VACCINE FORMULATION WITH THE CAPACITY TO INDUCE MULTI-FUNCTIONAL T CELL RESPONSES IN OVARIAN, BREAST AND PROSTATE CANCER PATIENTS
First-in-Man Application of a Novel Therapeutic Cancer Vaccine Formulation with the Capacity to Induce Multi-functional T Cell Responses in Ovarian, Breast and Prostate Cancer Patients.
STATHMIN 1: A PROTEIN WITH MANY TASKS. NEW BIOMARKER AND POTENTIAL TARGET IN CANCER
A Protein with Many Tasks. New Biomarker and Potential Target in Cancer (Editorial).
EWING’S SARCOMA: DEVELOPMENT OF RNA INTERFERENCE BASED THERAPY FOR ADVANCED DISEASE
Ewing’s Sarcoma: Development of RNA Interference Based Therapy for Advanced Disease.